Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
12.36
-2.66 (-17.71%)
At close: Nov 16, 2026

BOM:531015 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
132.5880.258.07---
Revenue Growth
333.17%894.04%380.89%---
Cost of Revenue
122.5272.847.950.1--
Gross Profit
10.067.410.12-0.1--
Selling, General & Admin
2.132.10.660.230.30.19
Other Operating Expenses
4.163.87-0.650.731.551.08
Operating Expenses
6.3360.081.021.941.36
Operating Income
3.731.40.05-1.12-1.94-1.36
Interest & Investment Income
1.371.37----
Other Non Operating Income (Expenses)
-0-01.994.1919.83
EBT Excluding Unusual Items
5.112.770.050.872.2618.47
Asset Writedown
---0.19---
Pretax Income
5.112.77-0.140.872.2618.47
Income Tax Expense
0.870.29-0.040.2200
Net Income
4.232.48-0.110.652.2618.46
Net Income to Common
4.232.48-0.110.652.2618.46
Net Income Growth
22.73%---71.41%-87.78%-
Shares Outstanding (Basic)
16125555
Shares Outstanding (Diluted)
16125555
Shares Change
216.05%121.09%---0.00%
EPS (Basic)
0.260.21-0.020.120.433.52
EPS (Diluted)
0.250.21-0.020.120.433.52
EPS Growth
-61.62%---72.09%-87.78%-

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-116.92-109.96-22.90.02-0.0319.05
Free Cash Flow Per Share
-7.12-9.49-4.370.00-0.013.64
Gross Margin
7.59%9.23%1.52%---
Operating Margin
2.81%1.75%0.58%---
Profit Margin
3.19%3.09%-1.30%---
Free Cash Flow Margin
-88.19%-137.03%-283.69%---
EBITDA
3.781.440.11-1.05-1.86-1.27
EBITDA Margin
2.85%1.80%1.38%---
D&A For EBITDA
0.050.040.060.070.080.09
EBIT
3.731.40.05-1.12-1.94-1.36
EBIT Margin
2.81%1.75%0.58%---
Effective Tax Rate
17.10%10.37%-25.74%0.04%0.02%
Revenue as Reported
134.1881.8518.611.994.1919.83
Advertising Expenses
-0.070.07---